Literature DB >> 12489277

The future of colorectal imaging: computed tomographic colonography.

Amy K Hara1.   

Abstract

The development of colorectal cancer screening alternatives that are attractive to patients and effective for screening is critical for reducing this too-common and deadly disease. CTC is an exciting technique that is the only imaging alternative developed since the barium enema for colon screening. In the past few years, many obstacles to clinical implementation of CTC have been eliminated. For example, there is no longer any post-processing time, which was previously as long as 8 to 10 hours, and the interpretation time has been drastically reduced from 4 hours to 15 to 20 minutes. The majority of studies have demonstrated excellent results for detection of lesions > or = 1 cm, with few false positives. This examination will continue to improve with the development of automated (computer) detection programs and automated 3D rendering algorithms. In addition, cathartic bowel preparation, one of the biggest obstacles to patient compliance with colorectal cancer screening, may be eliminated if successful fecal tagging can be developed. The most important issue that remains is its performance in a screening population, and studies are currently underway to answer that important question.

Entities:  

Mesh:

Year:  2002        PMID: 12489277     DOI: 10.1016/s0889-8553(02)00060-2

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  2 in total

1.  Does the amount of tagged stool and fluid significantly affect the radiation exposure in low-dose CT colonography performed with an automatic exposure control?

Authors:  Hyun Kyong Lim; Kyoung Ho Lee; So Yeon Kim; Kil Joong Kim; Bohyoung Kim; Hyunna Lee; Seong Ho Park; Jeffrey H Yanof; Seung-Sik Hwang; Young Hoon Kim
Journal:  Eur Radiol       Date:  2010-08-11       Impact factor: 5.315

2.  At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.

Authors:  Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber; Rob Boer; Janneke Wilschut; J Dik F Habbema
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.